Fibrin sealant use for minimising peri-operative allogeneic blood transfusion - Test2 - elhamkhani - TriplyDB

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

http://www.wikidata.org/entity/Q24250264

about

Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in patients without haemophilia Fibrin Sealants in Dura Sealing: A Systematic Literature Review The impact of blood management on length of stay after primary total knee arthroplasty Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database Patterns of use of hemostatic agents in patients undergoing major surgery.Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.An approach to transfusion and hemorrhage in trauma: current perspectives on restrictive transfusion strategies.Newer hemostatic agents used in the practice of dermatologic surgery.A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding.Topical haemostatic agents in liver surgery: do we need them?Evolution of the role of army transfusion services in the management of trauma patients and battle casualties with massive hemorrhage.Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats.Prevention of Hematomas and Seromas.Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty.Guidelines on transfusion for fetuses, neonates and older children.Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty.

P2860

Q24186135-AE8B6405-00ED-46D2-9FEC-082518557007 Q24201587-71B82EBB-2F3A-4B2E-A914-794FB6460DA8 Q30384006-83AC9DB2-43D5-4024-A81B-B98BB9764FC2 Q33696056-A8FCC5E4-A5C3-48B6-BEB6-FC825EEA17A2 Q34988663-EA1A6D39-7D82-4D0D-B776-E9E8966C539F Q35891985-A1979DDB-2E0E-46E1-BB89-061873124E82 Q36137393-31BB9BF5-A817-4A09-BE98-9547B0D5AD0E Q36515685-297D57DC-108A-47D7-BE14-2592465BBF5D Q36658472-DBC3D0A7-F634-40A5-90E0-DB715E04B86E Q37111243-CAAB757A-A59C-407A-8ACF-D0F7EF91889D Q37284019-4210C49B-FFEF-477C-AE83-7E151E3A2069 Q37305593-F1A48FF4-5D61-4975-85D9-768FE2546413 Q37390952-E39AC1F2-2E05-4FA4-A5F7-047906716842 Q38411128-A01AE8DA-B868-412E-8E4A-A923800DCF8B Q50416418-FCABBB96-F046-4038-852D-3CC964BAA44A Q50512600-088F2E09-F0B1-4FA3-A51E-FB88FBDD0570 Q53674609-D7109C51-79F8-40B7-ABC2-EA9DCCBF1D69 Q54662073-8227A3E2-F4C8-4009-92BE-64393650FCAA

P2860

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

http://www.wikidata.org/entity/Q24250264

description

2003 nî lūn-bûn

@nan

2003 թուականին հրատարակուած գիտական յօդուած

@hyw

2003 թվականին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@ast

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en-gb

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@nl

type

label

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@ast

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en-gb

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@nl

prefLabel

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@ast

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en-gb

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@nl

P1433

Q24250264-A641C3E3-98E4-4CDD-9573-81C05ED8C6ED

P1476

Q24250264-6A1E9B34-D83D-4929-85CD-DE7933C927BA

P2093

Q24250264-3FA95518-94AC-41D2-8A66-DCF421FA36E4

Q24250264-6F08AFA3-0DBF-4C22-891A-6C78D5240A42

Q24250264-7247FDB9-F640-46B6-8B54-A7CF7352E506

P2860

Q24250264-057D0FA0-79DD-41BF-A35E-0130E0D121B9

Q24250264-1A0CB135-6FA6-4C1A-AB3C-06BC02233EAF

Q24250264-22451928-BFDA-4A3D-BD26-31A7CDDBEAF3

Q24250264-2780472F-5AE2-4956-8629-9DF0469E4DC2

Q24250264-2B289730-7720-4A13-B84D-BFB428AFF934

Q24250264-2D861A32-EA78-42BE-82BD-E87C5EB03060

Q24250264-2E4364B4-AB84-4697-9686-9BE1A1C3EF1B

Q24250264-45A49452-7C6D-4059-8366-7D54579FD648

Q24250264-4B532C91-DB73-4832-8565-18440B0C3734

Q24250264-50E969CB-CB71-4DA5-AAD2-00D40DD4E168

P304

Q24250264-9B125291-124E-4634-8DDE-7D96744AADE5

P31

Q24250264-31A78580-35DD-4B9F-A6C3-D3DFC0AA7DBD

P3181

Q24250264-EB350293-DCB1-48D5-AD86-EA6025842C15

P356

Q24250264-CF860377-BBCB-47D6-B2F0-0BDE60D45166

P407

Q24250264-F9AFD460-26E7-4A3A-8C25-B07F9EDABA28

P433

Q24250264-B448BF99-75C4-41BD-BF14-2200E21303EA

P577

Q24250264-BA487A5F-BC1C-4FC3-886D-1AAF4076777A

P698

Q24250264-DFD69669-4AD1-483C-BC21-A4273152F96E

P932

Q24250264-DCC10D0E-F1BA-47E5-B35D-7466D7CE0A56

P3181

P356

14651858.CD004171

P1433

Cochrane Database of Systematic Reviews

P1476

Fibrin sealant use for minimising peri-operative allogeneic blood transfusion

@en

P2093

D A Henry

http://www.w3.org/2001/XMLSchema#string

D M Anthony

http://www.w3.org/2001/XMLSchema#string

P A Carless

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Meta-analysis in clinical trials

Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial.

Fibrin sealant: a review of its use in surgery and endoscopy.

Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion.

Economic analysis of erythropoietin use in orthopaedic surgery.

Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators.

P304

CD004171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2055345

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD004171

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12804501

http://www.w3.org/2001/XMLSchema#string

P932

4171968

http://www.w3.org/2001/XMLSchema#string